Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The randomized clinical trial: a prerequisite for rational therapy

M Staquet

    European Urology
    |January 1, 1976
    PubMed
    Summary

    Non-randomized trials in urological cancer yield biased results, hindering future treatment planning. More randomized controlled trials are needed, especially for antimitotic chemotherapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidelines for reporting results of quality of life assessments in clinical trials.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·1996
    Same author

    Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovary.

    American journal of clinical oncology·1987
    Same author

    Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects.

    Drugs under experimental and clinical research·1986
    Same author

    Standardization of format of reporting results.

    Progress in clinical and biological research·1986
    Same author

    Predictive tests for the response to cancer chemotherapy: limitations related to the prediction of rare events.

    Cancer treatment reports·1984
    Same author

    Predictive tests and infrequent events in cancer chemotherapy.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·1984

    Area of Science:

    • Urology
    • Oncology
    • Clinical Trials

    Background:

    • Non-randomized clinical trials in urological cancer often present contradictory findings.
    • Patient selection bias in these studies limits their utility for future treatment strategies.
    • There is a notable scarcity of randomized controlled trials in urological cancer research.

    Purpose of the Study:

    • To highlight the limitations of non-randomized trials in urological cancer.
    • To emphasize the need for more robust clinical trial designs.
    • To underscore the under-investigated role of antimitotic chemotherapy in urological malignancies.

    Main Methods:

    • Review of existing literature on clinical trials in urological cancer.
    • Analysis of bias in patient selection within non-randomized studies.
    • Identification of research gaps concerning antimitotic chemotherapy efficacy.

    Main Results:

    • Contradictory outcomes in urological cancer research are frequently linked to biased patient selection.
    • Existing data from non-randomized trials are insufficient for evidence-based therapeutic planning.
    • Randomized controlled trials are underrepresented in the field of urological oncology.

    Conclusions:

    • The current evidence base from non-randomized trials is inadequate for guiding urological cancer treatment.
    • There is a critical need to increase the number and quality of randomized controlled trials.
    • Further investigation into the efficacy of antimitotic chemotherapy is warranted for urological cancers.

    Related Experiment Videos